Новые возможности терапии скелетно-мышечной боли

@inproceedings{2019,
  title={Новые возможности терапии скелетно-мышечной боли},
  author={А. Б. Данилов and В. Б. Коржавина},
  year={2019}
}
Musculoskeletal pain (MSP) is one of the major interdisciplinary problems of modern medicine and society. Inflammation is a universal mechanism that plays a crucial role in the development of acute and chronic MSP. Therefore, non-steroidal antiinflammatory drugs (NSAIDs) are the first-line treatment for MSP. The effectiveness of all NSAIDs in reducing pain and inflammation is approximately the same, and the degree of safety is determined by their relationship to COX-1 and COX-2 enzymes. Thanks… 
2 Citations
Лечение пациента с болью в нижней части спины
TLDR
The clinical efficacy of dexketoprofen in NBS, osteoarthritis (OA) of different localization was shown and the efficiency of Nimesil administration in OA in patients with high risk of complications from the gastrointestinal tract (GIT) is shown.
Treating a patient with lower back pain
TLDR
The clinical efficacy of dexketoprofen in NBS, osteoarthritis (OA) of different localization was shown and the efficiency of Nimesil administration in OA in patients with high risk of complications from the gastrointestinal tract (GIT) is shown.

References

SHOWING 1-10 OF 25 REFERENCES
Нестероидные противовоспалительные препараты как первая ступень при лечении скелетно-мышечной боли
TLDR
Aceclofenac may be legally regarded as one of the most balanced NSAIDs in this respect and the data available in the literature on the use of this drug is reviewed, including the largest clinical and epidemiological studies.
КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ «Рациональное применение нестероидных противовоспалительных препаратов (НПВП) в клинической практике»
TLDR
The paper presents the new version of the clinical guidelines «Rational use of nonsteroidal anti-inflammatory drugs (NSAIDs) in clinical practice » prepared by the Association of Rheumatologists of Russia, the Russian Pain Society, and the Russian Gastroenterological Association, based on the results of well-organized clinical and large-scale population-based studies.
Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease.
TLDR
Tests of 2 to 6 months' duration have shown aceclofenac to be an effective agent in the management of pain and rheumatic disease and costs incurred as a result of adverse event management are lower with acecl ofenac than with a range of comparator NSAIDs.
Симптоматическая терапия боли при ревматических заболеваниях: место ацеклофенака
TLDR
Aceclofenac is an available effective NSAID, which is distinguished for its balanced analgesic and anti-inflammatory activities and a good tolerability and may be recommended for both rapid analgesia in urgent situations and long-term treatment of pain in chronic diseases.
[A short history of anti-rheumatic therapy. II. Aspirin].
TLDR
The property of this drug as an anti-platelet agent, thus opening the way for more widespread uses in cardiovascular diseases, is identified by Lawrence L. Crawen.
Patient and Physician Satisfaction with Aceclofenac: Results of the European Observational Cohort Study (Experience with Aceclofenac for Inflammatory Pain in Daily Practice)
TLDR
The findings of the European Observational Cohort study validate aceclofenac, in everyday clinical practice, as an effective, well-tolerated and well-accepted therapy for both acute and chronic inflammatory and degenerative disease.
[Therapy for acute/subacute musculoskeletal pain: results of the ATUSA (Analgesic Treatment Using a Systemic Algorithm) observational study].
TLDR
The comprehensive pathogenetic approach used in analgesic therapy provides an effective and relatively safe relief of MSP in most patients with NBP and osteoarthritis.
A double-blind, multicentre, randomised clinical trial comparing the efficacy and tolerability of aceclofenac with diclofenac resinate in patients with acute low back pain
TLDR
Non-inferiority of the analgesic efficacy of aceclofenac compared with dicl ofenac resinate was demonstrated in patients with localised, uncomplicated acute lumbosacral pain in a double-blind, multicentre randomised study.
Efficacy and Safety of Different Aceclofenac Treatments for Chronic Lower Back Pain: Prospective, Randomized, Single Center, Open-Label Clinical Trials
TLDR
In patients with CLBP, acecl ofenac CR and aceclofenac demonstrated significant symptomatic pain relief, improvement in quality of life and functional scores.
Diagnosing and treating chronic musculoskeletal pain based on the underlying mechanism(s).
  • D. Clauw
  • Medicine, Psychology
    Best practice & research. Clinical rheumatology
  • 2015
...
...